Open Access Repository

Acorda Therapeutics: Rebuilding the Spinal Cord

Murray, F, Kolesnik, M, Enriquez, J and West, J 2004 , Acorda Therapeutics: Rebuilding the Spinal Cord.

Full text not available from this repository.


Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic in-licensing choices, including what disease indication, what stage of development, how many molecules, and on what terms.

Learning Objective:
To allow students to examine a portfolio of choices and their impact on the overall business rather than on a single licensing decision.

New York, NY; United States; Biotechnology industry; start-up; 2003

Item Type: Report (Other)
Authors/Creators:Murray, F and Kolesnik, M and Enriquez, J and West, J
Publisher: Harvard Business School
DOI / ID Number: Case (Field) 9-604-014
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page